期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肿瘤PET代谢显像剂及其特点 被引量：1

Characteristics of metabolic imaging agents in PET oncology
原文传递
导出
摘要 随着肿瘤PET代谢显像技术的不断发展，其在肿瘤的诊断、治疗及评价等方面的应用也越来越广泛，同时对各种代谢显像剂的研究也日趋深入。综述了各种PET代谢显像剂的基本特性和临床应用，并重点对反映糖代谢、氨基酸代谢和胆碱代谢的显像剂进行评价和比较。 As the developing of the PET technology on metabolic imaging, the application in the diagnosis, treatment and evaluation of neoplasms is extending, this also promotes the research on various metabolic imaging agents. This article summarized the characteristics and clinical applications of different kinds of metabolic imaging agents, in which the glucose, amino acid and choline metabolic imaging agents are highlighted.
作者 向玲 张永学
机构地区 华中科技大学协和医院PET中心
出处 《国际放射医学核医学杂志》 2008年第3期133-136,共4页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 肿瘤 体层摄影术 发射型计算机 代谢显像剂 Neoplasms Tomography, emission-computed Metabolic imaging agents
分类号 R730 [医药卫生—肿瘤]
  • 相关文献

参考文献18

  • 1Kelloff GJ, Hoffman JM, Johnson B, et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development [J]. Clin Cancer Res, 2005, 11 (8): 2785-2808.
  • 2李家敏,孙启银,赵军,黄树林,王明芳,孙爱君.^(18)F-FDG PET显像在肝癌诊断及疗效评价中的应用[J].中华核医学杂志,1998,18(3):181-181. 被引量：8
  • 3丁勇,张书文,田嘉禾.FDG-PET在肿瘤学中的应用[J].中国医学影像学杂志,2000,8(6):469-471. 被引量：14
  • 4Kumar R, Loving VA, Chauhan A, et al. Potential of dual-timepoint imaging to improve breast cancer diagnosis with ^18F-FDG PET [J]. J Nucl Med, 2005, 46 (11): 1819-1824.
  • 5张永学,吴志坚,贾清,魏昊,兰晓莉,高再荣.^(18)F-FDGPET双时相显像在鉴别良恶性病变中的价值[J].中国医学影像技术,2006,22(9):1415-1417. 被引量：3
  • 6Lan XL, Zhang YX, Wu ZJ, et al. The value of dual time point ^18F- FDG PET imaging for the differentiation between malignant and benign lesions[J]. Clin Radiol, 2008, 63(7): 756-764.
  • 7Matheja P, Schober O. ^123I-IMT SPET: Introducing another research tool into clinical neuro-oncology [J]. Eur J Nucl Med, 2001, 28 (1): 1-4.
  • 8Jager PL, Vaalburg W, Pruim J, et al. Radiolabeled aminoacids: basic aspects and clinical appacations in oncology [J]. J Nucl Med, 2001, 42 (3): 432-445.
  • 9Goldman S, Levivier M, Pirotte B, et al. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy[J]. J Nucl Med, 1997, 38(9): 1459- 1462.
  • 10Pieterman R, Willemsen A, Appel M, et al. Visualisation and assessment of the protein synthesis rate of lung cancer using carnbon-11 tyrosine and positron emission tomography [J]. Eur J Nucl Med Mol Imaging, 2002, 29 (2): 243-247.

二级参考文献14

  • 1李家敏，中华核医学杂志，1997年，17卷，77页
  • 2李家敏，中华核医学杂志，1996年，16卷，136页
  • 3丁小强.肾脏肿瘤.见:陈灏珠,主编.实用内科学(下册).第8版.北京:人民卫生出版社,2003.2075-2086.
  • 4Liu RS,Hsich HJ,Guo WY,et al.Positron emission tomography with 1-^18C-acetate in meningiomas.J Nucl Med,2004,45:265.
  • 5Ho CL,Yu SCH,Yeung DWC.^11C-acetate PET imaging in bepatocellular carcinoma and other live masses.J Nucl Med,2003,44:213-221.
  • 6Fricke E,Machtens S.HoF-Fmann M,et al.Positron emission tamography with ^11C-acatate and ^18F-FDG in prostate cancer patients.Eur J Nucl Med Mol Imaging,2003,30:607-611.
  • 7Shreve P,Cluao PC,Humes HD,et al.^11C-acetate PET imaging in renal disense.J Nucl Med,1995,36:1595-1601.
  • 8Ho CL,Cheng TKC,Yeun DWC,et al.^11C-acetate PET imaging in the dieferentiation of renal angiomyolipoma and renal cell caremoma.J Nucl Med,2005,46:103.
  • 9Kumar R,Loving VA,Chauhan A,et al.Potential of dual-time-point imaging to improve breast cancer diagnosis with 18F-FDG PET[J].J Nucl Med,2005,46(11):1819-1824.
  • 10Zhuang H,Pourdehnad M,Lambright ES,et al.Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes[J].J Nucl Med,2001,42(9):1412-1417.

共引文献40

同被引文献10

引证文献1

二级引证文献13

国际放射医学核医学杂志
2008年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部